GlaxoSmithKline Pharmaceuticals informs about outcome of schedule of analyst meet

06 Aug 2024 Evaluate

Pursuant to Regulation 30 read with Part A of Schedule Ill of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, GlaxoSmithKline Pharmaceuticals has informed that the recording is uploaded at https://indiapharma.gsk.com/en-in/investors/analyst-meets/.

The above information is a part of company’s filings submitted to BSE.


Glaxosmithkline Phar Share Price

2650.85 31.45 (1.20%)
25-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1763.80
Dr. Reddys Lab 1306.60
Cipla 1345.70
Zydus Lifesciences 919.40
Lupin 2292.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×